| BICYCLE THERAPEUTICS ADR |
| USA |
| Gesundheit |
| US0887861088 / A2PKZC |
| 50BA (Frankfurt) / BCYC (NASDAQ) |
| FRA:50BA, ETR:50BA, 50BA:GR, NASDAQ:BCYC |
| - |
| https://www.bicycletherap.. |
|
Bicycle Therapeutics plc is a biopharmaceutical company developing precision-guided therapeutics to treat solid tumors. The company specializes in bicyclic peptides, a novel class of fully synthetic, chemically-derived medicines formed by constrainin..
>Volltext.. |
| 265.85 Mio. EUR |
| -211.17 Mio. EUR |
| 55.57 Mio. EUR |
| -236.39 Mio. EUR |
| -192.45 Mio. EUR |
| -2.77 EUR |
| 13.98 Mio. EUR |
| 490.99 Mio. EUR |
| -201.1 Mio. EUR |
| 11.45 |
| 146.03% |
| -7.85% |
| - |
| - |
| - |
| - |
| BICYCLE THERAPEUTICS, BICYCLE THERAPEUTIC |
| 08.07.26 |
|